Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 21076 AL 21090

Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality

Hudry E, Vandenberghe LH.

Neuron. 2019 Mar 6;101(5):839-862. doi: 10.1016/j.neuron.2019.02.017.

A systematic review and meta-analysis of the associations of vitamin D receptor genetic variants with two types of most common neurodegenerative disorders

Geng J, Zhang J, Yao F, Liu X, Liu J, Huang Y.

Aging Clin Exp Res. 2020 Jan;32(1):21-27. doi: 10.1007/s40520-019-01135-4. Epub 2019 Mar 12.

Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?

Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH.

J Neurovirol. 2019 Oct;25(5):634-647. doi: 10.1007/s13365-019-00732-3. Epub 2019 Mar 13.

To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling

Javadpour P, Dargahi L, Ahmadiani A, Ghasemi R.

Cell Mol Life Sci. 2019 Jun;76(12):2277-2297. doi: 10.1007/s00018-019-03063-y. Epub 2019 Mar 14.

Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review

Dinda B, Dinda M, Kulsi G, Chakraborty A, Dinda S.

Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8.

Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease

Vöglein J, Paumier K, Jucker M, Preische O, McDade E, Hassenstab J, Benzinger TL, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, Farlow MR, Chhatwal J, Salloway S, Xiong C, Karch CM, Cairns N, Mori H, Schofield PR, Masters CL, Goate A, Buckles V, Fox N, Rossor M, Chrem P, Allegri R, Ringman JM, Höglinger G, Steiner H, Dieterich M, Haass C, Laske C, Morris JC, Bateman RJ, Danek A, Levin J; Dominantly Inherited Alzheimer Network.

Brain. 2019 May 1;142(5):1429-1440. doi: 10.1093/brain/awz050.

An Overview of Primary Dementias as Clinicopathological Entities

Salardini A.

Semin Neurol. 2019 Apr;39(2):153-166. doi: 10.1055/s-0039-1683445. Epub 2019 Mar 29.

CSF Cytokines in Aging, Multiple Sclerosis, and Dementia

Hu WT, Howell JC, Ozturk T, Gangishetti U, Kollhoff AL, Hatcher-Martin JM, Anderson AM, Tyor WR.

Front Immunol. 2019 Mar 15;10:480. doi: 10.3389/fimmu.2019.00480. eCollection 2019.

Autophagy at synapses in neurodegenerative diseases

Lee W, Kim SH.

Arch Pharm Res. 2019 May;42(5):407-415. doi: 10.1007/s12272-019-01148-7. Epub 2019 Apr 1.

Recent Advances in Apoptosis: THE Role of Hydrazones

Çıkla-Süzgün P, Küçükgüzel ŞG.

Mini Rev Med Chem. 2019;19(17):1427-1442. doi: 10.2174/1389557519666190410125910.

Emerging drugs for progressive supranuclear palsy

Giagkou N, Stamelou M.

Expert Opin Emerg Drugs. 2019 Jun;24(2):83-92. doi: 10.1080/14728214.2019.1609450. Epub 2019 May 20.

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Staff NP, Jones DT, Singer W.

Mayo Clin Proc. 2019 May;94(5):892-905. doi: 10.1016/j.mayocp.2019.01.001.

Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers: A Cluster-Randomized Double-Blind Controlled Trial

Cheng ST, Chan WC, Lam LCW.

Am J Geriatr Psychiatry. 2019 Sep;27(9):984-994. doi: 10.1016/j.jagp.2019.03.013. Epub 2019 Mar 26.

Modification of the gut microbiome to combat neurodegeneration

Sasmita AO.

Rev Neurosci. 2019 Nov 26;30(8):795-805. doi: 10.1515/revneuro-2019-0005.

Toxoplasma gondii infection and risk of Parkinson and Alzheimer diseases: A systematic review and meta-analysis on observational studies

Bayani M, Riahi SM, Bazrafshan N, Ray Gamble H, Rostami A.

Acta Trop. 2019 Aug;196:165-171. doi: 10.1016/j.actatropica.2019.05.015. Epub 2019 May 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias